We are live on ! Find out more
MBE

Michael B. Elefante Portfolio holdings

AUM $91.5M Turnover 27.89%
1-Year Est. Return 13.24%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$231M
AUM Growth
+$14.3M
Cap. Flow
+$10.4M
Cap. Flow %
4.51%
Top 10 Hldgs %
31.83%
Holding
146
New
35
Increased
57
Reduced
31
Closed
6
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$1.19M
2
TGT icon
Target
TGT
+$645K
3
XLNX
Xilinx Inc
XLNX
+$524K
4
FISV icon
Fiserv Inc
FISV
+$483K
5
IPGP icon
IPG Photonics
IPGP
+$386K

Top Sells

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$595K
2
SYK icon
Stryker
SYK
+$258K
3
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$228K
4
GIS icon
General Mills
GIS
+$227K
5
COL
Rockwell Collins
COL
+$216K

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Healthcare 23.62%
3 Industrials 17.11%
4 Energy 10.93%
5 Miscellaneous 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RTX icon
26
RTX Corp
RTX
$251B
$3.84M 1.66%
52,240
+3,107
+6% +$223K
2013 Q2
3 quarters
JCI icon
27
Johnson Controls International
JCI
$92.3B
$3.84M 1.66%
77,427
+6,313
+9% +$320K
2013 Q2
3 quarters
PBA icon
28
Pembina Pipeline
PBA
$28.2B
$3.78M 1.64%
99,340
+2,490
+3% +$87.9K
2013 Q2
3 quarters
QCOM icon
29
Qualcomm
QCOM
$184B
$3.71M 1.6%
47,015
+15,745
+50% +$1.19M
2013 Q2
3 quarters
IPGP icon
30
IPG Photonics
IPGP
$3.13B
$3.45M 1.49%
48,590
+5,490
+13% +$386K
2013 Q2
3 quarters
MSFT icon
31
Microsoft
MSFT
$3.96T
$2.6M 1.12%
63,416
+450
+0.7% +$16.9K
2013 Q2
3 quarters
ABB
32
DELISTED
ABB Ltd
ABB
$2.39M 1.03%
92,675
-1,000
-1% -$25.4K
2013 Q2
3 quarters
LH icon
33
Labcorp
LH
$25.7B
$2.38M 1.03%
28,210
+2,288
+9% +$182K
2013 Q2
3 quarters
HD icon
34
Home Depot
HD
$295B
$2.34M 1.01%
29,598
+1,620
+6% +$129K
2013 Q2
3 quarters
CSCO icon
35
Cisco
CSCO
$448B
$2.27M 0.98%
101,313
+1,150
+1% +$25.4K
2013 Q2
3 quarters
ABT icon
36
Abbott
ABT
$178B
$1.98M 0.86%
51,495
+4,550
+10% +$175K
2013 Q2
3 quarters
SPY icon
37
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$1.8M 0.78%
9,625
– –
2013 Q2
3 quarters
TGT icon
38
Target
TGT
$70.6B
$1.52M 0.66%
25,200
+10,885
+76% +$645K
2013 Q3
2 quarters
GIS icon
39
General Mills
GIS
$17.2B
$1.45M 0.63%
28,035
-4,580
-14% -$227K
2013 Q2
3 quarters
GE icon
40
GE Aerospace
GE
$319B
$1.28M 0.55%
10,293
+150
+1% +$18.5K
2013 Q2
3 quarters
MRK icon
41
Merck
MRK
$364B
$1.14M 0.49%
20,965
-142
-0.7% -$7.35K
2013 Q2
3 quarters
HON icon
42
Honeywell
HON
$65.8B
$1.11M 0.48%
13,299
-262
-2% -$21.7K
2013 Q2
3 quarters
DD icon
43
DELISTED
Du Pont De Nemours E I
DD
$1.03M 0.44%
16,104
-607
-4% -$37.1K
2013 Q2
3 quarters
XLNX
44
DELISTED
Xilinx Inc
XLNX
$985K 0.43%
18,150
+10,550
+139% +$524K
2013 Q4
1 quarter
IBM icon
45
IBM
IBM
$215B
$981K 0.42%
5,330
-904
-15% -$159K
2013 Q2
3 quarters
ABBV icon
46
AbbVie
ABBV
$501B
$768K 0.33%
14,950
– –
2013 Q2
3 quarters
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.13T
$675K 0.29%
5,400
– –
2013 Q2
3 quarters
DE icon
48
Deere & Co
DE
$175B
$672K 0.29%
7,400
-2,165
-23% -$189K
2013 Q2
3 quarters
NVO icon
49
Novo Nordisk
NVO
$168B
$651K 0.28%
28,500
-2,000
-7% -$42.6K
2013 Q2
3 quarters
WMT icon
50
Walmart Inc
WMT
$922B
$607K 0.26%
23,847
– –
2013 Q2
3 quarters
1
2
3 4 5

Similar funds

AEPI
AH Equity Partners II Menlo Park, California $91.5M AUM
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
TM
TigerShark Management New York $98.9M AUM 11.4% 1-Year Est. Return
VNB
Valley National Bancorp New York $81.9M AUM 5.36% 1-Year Est. Return
ECP
Empirical Capital Partners Ringgold, Georgia $101M AUM
WIL
Winifred I. Li $106M AUM 11.93% 1-Year Est. Return
RCM
Raptor Capital Management Boston, Massachusetts $73.2M AUM 23.77% 1-Year Est. Return
ZTNA
Zions Trust National Association Salt Lake City, Utah $69.4M AUM 2.73% 1-Year Est. Return

Michael B. Elefante's Q1 2014 Portfolio in Review

As of Q1 2014, Michael B. Elefante held 146 positions worth $231M, up 6.6% from $217M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Michael B. Elefante deployed $10.4M of net new capital in Q1 2014, opening 35 new positions and adding to 57 existing holdings. Its largest new stake was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $595K trimmed.

  • Michael B. Elefante's largest Q1 2014 buy was CITY NATIONAL CORPORATION: 3,900 shares worth $307K.
  • Michael B. Elefante added most to Qualcomm in Q1 2014, an estimated $1.19M increase.
  • Michael B. Elefante's biggest Q1 2014 reduction was Alnylam Pharmaceuticals, cutting an estimated $595K.
  • Michael B. Elefante fully exited Stryker in Q1 2014, selling an estimated $258K.
  • Michael B. Elefante's ten largest holdings make up 32% of its $231M portfolio in Q1 2014.
  • Michael B. Elefante opened 35 new positions and closed 6 in Q1 2014.
  • Michael B. Elefante's portfolio value rose 6.6% quarter-over-quarter to $231M.

Based on Michael B. Elefante's 13F filing for Q1 2014, filed 29 May 2014.